“…To investigate whether such treatments could also restore the normal rhythm of PER2 expression in the 6-OHDA-lesioned dorsal striatum, we gave systemic injections of the D 1 DA agonist, SKF 81297 (1 mg/kg), the D 2/3 DA agonist, quinpirole (0.5 mg/kg), or vehicle (1 ml/kg) at ZT1 for 10 d, beginning 15 d after surgery. Drug doses were in the range shown previously to enhance expression of immediate-early genes, striatal peptides, and electrophysiological responses of striatal neurons in 6OHDA-lesioned rats (Gerfen et al, 1990(Gerfen et al, , 1995Hu et al, 1992;Zhang et al, 2007;Ballion et al, 2009). We chose to give the daily agonist injection at ZT1, a time at which extracellular DA levels in the striatum are normally low, to determine whether exogenous stimulation of DA receptors would not only restore PER2 expression in the lesioned striatum, but also establish a new rhythm of PER2 expression whose phase was determined by the time of the agonist injection.…”